Evidence map›Paper›PMID 26390058›Full record

ArticleNature genetics2015

Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation.

Alvaro J González, Manu Setty, Christina S Leslie

Abstract read
In one paragraph

Article in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alvaro J GonzálezComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Manu SettyComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Christina S LeslieComputational Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

Decoding in vivo regulatory programs of CD4+ T lymphocyte populations in inflammaU01HG007893 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S, RUDENSKY, ALEXANDER Y · 2015 to 2017
$3.1M
Linking disease-associated variants to transcriptional regulation using ENCODEU01HG007033 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI KLEIN, ROBERT J. · 2012 to 2015
$1.9M
Integrative analysis tools to dissect cell-type specific transcriptional programsR01HG006798 · NHGRI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S · 2012 to 2014
$1.6M
NHGRI NIH HHS R01 HG006798NHGRI NIH HHS R01-HG006798NHGRI NIH HHS U01 HG007033NHGRI NIH HHS U01-HG007033NHGRI NIH HHS U01 HG007893NHGRI NIH HHS U01-HG007893
6 · The paper itself

Abstract

We carried out an integrative analysis of enhancer landscape and gene expression dynamics during hematopoietic differentiation using DNase-seq, histone mark ChIP-seq and RNA sequencing to model how the early establishment of enhancers and regulatory locus complexity govern gene expression changes at cell state transitions. We found that high-complexity genes-those with a large total number of DNase-mapped enhancers across the lineage-differ architecturally and functionally from low-complexity genes, achieve larger expression changes and are enriched for both cell type-specific and transition enhancers, which are established in hematopoietic stem and progenitor cells and maintained in one differentiated cell fate but lost in others. We then developed a quantitative model to accurately predict gene expression changes from the DNA sequence content and lineage history of active enhancers. Our method suggests a new mechanistic role for PU.1 at transition peaks during B cell specification and can be used to correct assignments of enhancers to genes.

Indexed as

Gene Expression RegulationAnimalsCell DifferentiationCell LineageEnhancer Elements, GeneticHematopoiesisHematopoietic Stem CellsHistonesHumansLysineMethylationModels, GeneticPromoter Regions, GeneticRegression AnalysisTime FactorsHistonesLysine

Identifiers

PMID26390058
PMCPMC4626279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.